STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

MFS Large Cap Growth Equity

MFS Massachusetts Inv Gr Stk A

MFS Mid Cap Growth Equity

MFS Mid Cap Growth A

Touchstone Mid Cap Y

Janus Inst Mid Cap Growth CF

Janus Henderson Enterprise D

Franklin Rising Dividends Fund A

The Health Care Select Sector SPDR® ETF

Vanguard Growth Index Investor

Vanguard Mid Cap Index Institutional

WCM Focused International Growth Instl

WCM Inv Mgt Focused Growth Intl

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

MS INVF Global Brands A

Morgan Stanley Glbl Franchise

iShares Core S&P 500 ETF

Vanguard Group Inc

BlackRock Inc

AllianceBernstein L.P.

Sustainable Growth Advisers, LP

NORGES BANK

Bessemer Group Inc

Northern Trust Corp

Impax Asset Management Group PLC

Principal Financial Group Inc

Pictet Asset Manangement SA

Mitsubishi UFJ Asset Management Co.,Ltd

JPMorgan Chase & Co

Massachusetts Financial Services Company

WCM Investment Management

State Street Corp

Morgan Stanley - Brokerage Accounts

Generation Investment Management LLP

Apg All Pensions Group

Geode Capital Management, LLC

HHG PLC

STERIS plc

Mr. Daniel A. Carestio

President, CEO & Director

Mr. Michael J. Tokich

Senior VP & CFO

Mr. John Adam Zangerle

Senior VP, General Counsel & Secretary

Ms. Mary Clare Fraser

SVP & Chief Human Resources Officer

Mr. Cary L. Majors

Senior VP & President of Healthcare

Ms. Karen L. Burton

VP & Chief Accounting Officer

Ms. Julie  Winter

Vice President of Investor Relations & Corporate Communications

Ms. Julia K. Madsen

Senior VP & GM of Life Sciences

Mr. Andrew  Xilas

Senior VP & GM of Dental

Mr. Kenneth E. Kohler

Senior VP & GM of AST

STE's next earnings is on February 5, 2025 (After Market Close)

STE's latest dividend is 0.57 USD on September 5, 2024

STERIS plc (STE) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

STERIS plc (STE) Earnings Report Date and History | NYSE

STE's next earnings is on February 5, 2025 (After Market Close)

When is the earnings report for STE?

STE Earnings History

STE's latest dividend is 0.57 USD on September 5, 2024

STE Stock Discussion Forum and Message Board

News for NYSE: STE